CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 3,806 shares at $6.27 ($23,864)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 814,874 shares at $4.25 ($3,463,215)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
Page 5 of 14 · 268 filings